FIELD: pharmacology.
SUBSTANCE: composition is a niosomal gel containing the niosome-encapsulated synthesized N-hydroxy-2-(2-(naphthalene-2-yl)-1H-indole-3-yl)-2-phenylacetamide.
EFFECT: implementation of the invention allows to increase the efficiency of antitumor substance transport into the target cells, thereby increasing the therapeutic effect of the niosomal gel for the treatment of glioblastoma.
1 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
DOXORUBICIN AND ORGANOSILICON NANOPARTICLES-NIOSOMES- BASED PHARMACEUTICAL GEL FOR SKIN CANCER TREATING | 2014 |
|
RU2600164C2 |
METHOD FOR TRANSDERMAL TRANSFER OF ACTIVE SUBSTANCES WITH USE OF PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539396C2 |
TRANSDERMAL ANTHELMINTIC AGENT OF SILICONE NIOSOMES WITH ALBENDAZOLE | 2013 |
|
RU2541156C1 |
METHOD FOR MAKING TRANSDERMAL PATCH CONTAINING PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539397C2 |
METHOD OF PRODUCING NIOSOMAL FORM OF OFLOXACIN | 2014 |
|
RU2583135C1 |
NIOSOMAL ANTIMICROBIAL GEL FOR TREATING DIABETIC ULCERS, WOUNDS, BURNS, INCLUDING THOSE INFECTED WITH ANTIBIOTIC-RESISTANT MICROORGANISMS | 2021 |
|
RU2781402C2 |
SYSTEM FOR DELIVERY OF BIOACTIVE SUBSTANCES BY USING NIOSOMES | 2006 |
|
RU2320323C1 |
SILICON-ORGANIC NIOSEMES WITH BACTERICIDAL AND PARAMAGNETIC PROPERTIES | 2016 |
|
RU2625722C1 |
MOISTENING SERUM FOR FACE "VITA" | 2007 |
|
RU2376982C2 |
SUN-PROTECTION GEL FOR FACE "SUN FIGHT" SPF 35 | 2007 |
|
RU2376981C2 |
Authors
Dates
2017-08-08—Published
2015-08-04—Filed